Sage Therapeutics

^{Priced, Nasdaq: SAGE}

Developing treatments for life-threatening epileptic seizures.

Industry: Health Care

First Day Return: +67.2%

SAGE

Developing treatments for life-threatening epileptic seizures.

IPO News for Sage Therapeutics

Epilepsy device maker NeuroSigma sets terms for $50 million IPO 09/29/14
Epilepsy device maker NeuroSigma files for a $50 million IPO 08/26/14
July could reach 40 IPOs 07/24/14

IPO Data
IPO Date	07/17/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$90
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.sagerx.com
Headquarters	Cambridge, MA, United States
Founded	2010
Employees at IPO	25

IPO News for Sage Therapeutics

Epilepsy device maker NeuroSigma sets terms for $50 million IPO 09/29/14
Epilepsy device maker NeuroSigma files for a $50 million IPO 08/26/14
July could reach 40 IPOs 07/24/14

Sage Therapeutics (SAGE) Performance